Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor

A. Schram; M. Borad; V. Sahai; S. Kamath; R. Kim; C. Y.A. Liao; D. Y. Oh; M. Ponz-Sarvisé; J. Yachnin; S. A. Shell; P. Cassier; E. Dotan; V. Florou; V. Moreno; J. O. Park; D. Tai; O. Schmidt-Kittler; C. Ferté; L. Goyal; V. Subbiah

doi:10.1016/S0959-8049(22)01110-8

Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor

A. Schram, M. Borad, V. Sahai, S. Kamath, R. Kim, C. Y.A. Liao, D. Y. Oh, M. Ponz-Sarvisé, J. Yachnin, S. A. Shell, P. Cassier, E. Dotan, V. Florou, V. Moreno, J. O. Park, D. Tai, O. Schmidt-Kittler, C. Ferté, L. Goyal, V. Subbiah

Hematology/Oncology

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	S116
Journal	European Journal of Cancer
Volume	174
DOIs	https://doi.org/10.1016/S0959-8049(22)01110-8
State	Published - Oct 2022

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1016/S0959-8049(22)01110-8

Cite this

Schram, A., Borad, M., Sahai, V., Kamath, S., Kim, R., Liao, C. Y. A., Oh, D. Y., Ponz-Sarvisé, M., Yachnin, J., Shell, S. A., Cassier, P., Dotan, E., Florou, V., Moreno, V., Park, J. O., Tai, D., Schmidt-Kittler, O., Ferté, C., Goyal, L., & Subbiah, V. (2022). Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor. European Journal of Cancer, 174, S116. https://doi.org/10.1016/S0959-8049(22)01110-8

Schram, A, Borad, M, Sahai, V, Kamath, S, Kim, R, Liao, CYA, Oh, DY, Ponz-Sarvisé, M, Yachnin, J, Shell, SA, Cassier, P, Dotan, E, Florou, V, Moreno, V, Park, JO, Tai, D, Schmidt-Kittler, O, Ferté, C, Goyal, L & Subbiah, V 2022, 'Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor', European Journal of Cancer, vol. 174, pp. S116. https://doi.org/10.1016/S0959-8049(22)01110-8

@article{5433cda5c3cf486f9f804f5c3e845723,

title = "Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor",

author = "A. Schram and M. Borad and V. Sahai and S. Kamath and R. Kim and Liao, {C. Y.A.} and Oh, {D. Y.} and M. Ponz-Sarvis{\'e} and J. Yachnin and Shell, {S. A.} and P. Cassier and E. Dotan and V. Florou and V. Moreno and Park, {J. O.} and D. Tai and O. Schmidt-Kittler and C. Fert{\'e} and L. Goyal and V. Subbiah",

year = "2022",

month = oct,

doi = "10.1016/S0959-8049(22)01110-8",

language = "English (US)",

volume = "174",

pages = "S116",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor

AU - Schram, A.

AU - Borad, M.

AU - Sahai, V.

AU - Kamath, S.

AU - Kim, R.

AU - Liao, C. Y.A.

AU - Oh, D. Y.

AU - Ponz-Sarvisé, M.

AU - Yachnin, J.

AU - Shell, S. A.

AU - Cassier, P.

AU - Dotan, E.

AU - Florou, V.

AU - Moreno, V.

AU - Park, J. O.

AU - Tai, D.

AU - Schmidt-Kittler, O.

AU - Ferté, C.

AU - Goyal, L.

AU - Subbiah, V.

PY - 2022/10

Y1 - 2022/10

UR - http://www.scopus.com/inward/record.url?scp=85140454096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85140454096&partnerID=8YFLogxK

U2 - 10.1016/S0959-8049(22)01110-8

DO - 10.1016/S0959-8049(22)01110-8

M3 - Article

AN - SCOPUS:85140454096

SN - 0959-8049

VL - 174

SP - S116

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this